Top Markets
Coin of the day
Instem plc Instem plc

Instem plc

INS
주식 순위 #19527
Established in 1969 and based in Stone, United Kingdom, Instem plc provides... Established in 1969 and based in Stone, United Kingdom, Instem plc provides information technology applications to the global life sciences and healthcare sectors. The company's core mission is to equip organizations with robust solutions for data capture, management, and analysis, thereby facilitating informed, data-driven decision-making processes. Instem's extensive suite of offerings addresses diverse needs across research and development. For early-phase clinical trials, it offers ALPHADAS, an eSource system. Discovery research is supported by tools like BioRails for data management and Morphit for data visualization. The portfolio also includes computational toxicology products and services, alongside Provantis, a Windows-based system for non-clinical evaluation studies. Specialized solutions comprise Comet Assay IV, a live video imaging system for reproducible comet slide scoring, and Cyto Study Manager for cytology data acquisition and reporting. Furthermore, NOTOCORD-hem software platforms are available for acquiring, displaying, and analyzing physiological signals. A significant area of focus is regulatory information management. Instem provides Samarind RMS for managing medical product information and a comprehensive set of tools for the Standard for Exchange of Nonclinical Data (SEND). This includes the submit platform for creating and managing SEND datasets, SENDView for reviewing them, SEND Explorer for web-based access with optional data warehousing, and SENDTrial, a subscription-based web solution. Other offerings include Logbook, an information repository, and the Sorcerer Colony Counter for automatic plate counting. Beyond its software products, Instem delivers a broad range of services such as sales support, training, validation, consultancy, and cloud services, in addition to safety assessment and regulatory information management software. The company also develops, manufactures, and supplies both software and hardware specifically for in vitro study data collection and management, enabling intelligence extraction from R&D related healthcare data.
주가
$10.38
마지막 동기화: 2023-11-20
시가총액
$158.81M
변동 (1일)
-7.99%
변동 (1년)
0.00%
국가
GB
거래 Instem plc (INS)

카테고리

B의 시가 총액을 가진 INS의 가격
Instem plc Instem plc
INS
$10.38
의 시가총액 Instem plc(INS)
시가총액: $158.81M
August 2026 기준으로 Instem plc의 시가총액은 $158.81M입니다. 이는 당사 데이터에 따르면 Instem plc이 세계에서 19527th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2010부터 2026까지 Instem plc의 시가총액 기록
INS 가장 인기있는 상위 5 가지 stocks과 비교하여
INS의 가격 자산 b b의 시장 결과
Instem plc Instem plc
$336,719 $158.81M
$5.152T +3,244,331.71%
Instem plc Instem plc
$296,498 $158.81M
$4.537T +2,856,783.22%
Instem plc Instem plc
$272,419 $158.81M
$4.169T +2,624,774.67%
Instem plc Instem plc
$238,031 $158.81M
$3.642T +2,293,424.81%
Instem plc Instem plc
$183,290 $158.81M
$2.805T +1,765,973.34%